A Pharmacoeconomic Analysis of In-Hospital Costs Resulting from Reintubation in Preterm Infants Treated with Lucinactant, Beractant, or Poractant Alfa

OBJECTIVES: Reintubation and subsequent mechanical ventilation (MV) in preterm infants after surfactant replacement therapy are associated with excess morbidity and mortality and likely increase in-hospital costs. Specific surfactant therapy selection for prevention of respiratory distress syndrome...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Guardia, Carlos G., Moya, Fernando R., Sinha, Sunil, Simmons, Phillip D., Segal, Robert, Greenspan, Jay S.
Médium: Artigo
Jazyk:Inglês
Vydáno: Pediatric Pharmacy Advocacy Group 2012
Témata:
Clinical Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3526925/
https://ncbi.nlm.nih.gov/pubmed/23258964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-17.3.220
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky